Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3921]

Accelerated partial breast irradiation not equivalent to whole breast...

Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA

Accelerated partial breast irradiation not equivalent to whole breast irradiation ( Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA )

Axillary radiotherapy and surgery show comparable long term outcomes for...

Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands

Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer ( Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands )

Low-dose tamoxifen reduces recurrence and new breast disease

Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy

Low-dose tamoxifen reduces recurrence and new breast disease ( Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy )

Adjuvant capecitabine did not significantly improve outcomes for breast cancer...

Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for...

Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )

Two clinical trials using combination therapy in adult patients with multiple...

Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Two clinical trials using combination therapy in adult patients with multiple myeloma ( Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

Gilteritinib combined with induction and consolidation chemotherapy in newly...

Dr Keith Pratz - Johns Hopkins University, Baltimore, USA

Gilteritinib combined with induction and consolidation chemotherapy in newly diagnosed AML patients ( Dr Keith Pratz - Johns Hopkins University, Baltimore, USA )

Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

Matched targeted therapy for paediatric patients with relapsed, refractory or...

Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA

$Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )$

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

$Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )$

ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline...

Dr Lorenz Trümper - Georg August University, Göttingen, Germany

ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas ( Dr Lorenz Trümper - Georg August University, Göttingen, Germany )

More from ecancer